Drug maker Pfizer Inc. said Oct. 23 a Spanish court upheld a patent covering the active ingredient in its blockbuster cholesterol drug Lipitor, reversing a lower court decision. Pfizer said Lek Pharmaceutical's challenge is one of four others by generic companies in Spain to the calcium salt patent, which covers Lipitor's active ingredient.
October 23, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Drug maker Pfizer Inc. said Oct. 23 a Spanish court upheld a patent covering the active ingredient in its blockbuster cholesterol drug Lipitor, reversing a lower court decision.
The decision by the Court of Appeal of Barcelona follows a patent challenge by Novartis AG’s generic unit Lek Pharmaceuticals D.D.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
